Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma
Ott, P. A., Hamid, O., Pavlick, A. C., Kluger, H., Kim, K. B., Boasberg, P. D., Simantov, R., Crowley, E., Green, J. A., Hawthorne, T., Davis, T. A., Sznol, M., Hwu, P.Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2013.54.8115
Date:
November, 2014
File:
PDF, 254 KB
english, 2014